Cover Image

Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.

Lymphatic filarial parasites survive within the lymphatic vessels for years despite the complex immune environment surrounding them. Parasites possibly accomplish this by adopting various immunomodulatory strategies, which include release of glutathione-S-transferases (GSTs) that counteract the oxid...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anandharaman Veerapathran (Author), Gajalakshmi Dakshinamoorthy (Author), Munirathinam Gnanasekar (Author), Maryada Venkata Rami Reddy (Author), Ramaswamy Kalyanasundaram (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2009-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification and characterization of a novel nematode pan allergen (NPA) from Wuchereria bancrofti and their potential role in human filarial tropical pulmonary eosinophilia (TPE).
by: Samuel Christopher Katru, et al.
Published: (2024)

Interruption of lymphatic filariasis transmission in Manaus, a former focus of Wuchereria bancrofti in the Western Brazilian Amazon
by: Marilaine Martins, et al.
Published: (2021)

Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.
by: Samuel Wanji, et al.
Published: (2019)

COVID-19 unfolding filariasis: The first case of SARS-CoV-2 and Wuchereria bancrofti coinfection.
by: Mouhand F H Mohamed, et al.
Published: (2020)

Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test.
by: Housseini Dolo, et al.
Published: (2019)

Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti.
by: Kathrin Arndts, et al.
Published: (2012)

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.
by: Sarah E Greene, et al.
Published: (2022)

Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections
by: Sarah E. Greene, et al.
Published: (2022)

Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection.
by: Joseph Kubofcik, et al.
Published: (2012)

Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
by: Shantanu K Kar, et al.
Published: (2017)

Wuchereria bancrofti infection is linked to systemic activation of CD4 and CD8 T cells.
by: Inge Kroidl, et al.
Published: (2019)

An analysis of genetic diversity and inbreeding in Wuchereria bancrofti: implications for the spread and detection of drug resistance.
by: Thomas S Churcher, et al.
Published: (2008)

Detection of Wuchereria bancrofti in the city of São Luís, state of Maranhão, Brazil: New incursion or persisting problem?
by: Tatiane Alexandre de Araújo, et al.
Published: (2023)

Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti.
by: Katy L Hamlin, et al.
Published: (2012)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India.
by: Abhishek Kumar Singh, et al.
Published: (2023)

Molecular xenomonitoring for Wuchereria bancrofti in Culex quinquefasciatus in two districts in Bangladesh supports transmission assessment survey findings.
by: Seth R Irish, et al.
Published: (2018)

A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
by: Cédric B Chesnais, et al.
Published: (2017)

Detection of Wuchereria bancrofti L3 larvae in mosquitoes: a reverse transcriptase PCR assay evaluating infection and infectivity.
by: Sandra J Laney, et al.
Published: (2010)

Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
by: Jonathan Mnkai, et al.
Published: (2022)

Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
by: Christina A Bulman, et al.
Published: (2015)

Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history.
by: Scott T Small, et al.
Published: (2013)

A randomized controlled trial of increased dose and frequency of albendazole with standard dose DEC for treatment of Wuchereria bancrofti microfilaremics in Odisha, India.
by: Shantanu Kumar Kar, et al.
Published: (2015)

Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment.
by: Manuel Ritter, et al.
Published: (2019)

Integrated xenosurveillance of Loa loa, Wuchereria bancrofti, Mansonella perstans and Plasmodium falciparum using mosquito carcasses and faeces: A pilot study in Cameroon.
by: Joseph Pryce, et al.
Published: (2022)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
by: Constant Edi, et al.
Published: (2019)

Lymphatic Filariasis in Sri Lanka
by: C. Harriet Gautamadasa
Published: (2001)

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015)

Kolaviron shows anti-proliferative effect and down regulation of vascular endothelial growth factor-C and toll like receptor-2 in Wuchereria bancrofti infected blood lymphocytes
by: Aliyu Muhammad, et al.
Published: (2017)

How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
by: Randee J Kastner, et al.
Published: (2017)

Mapping the geographical distribution of lymphatic filariasis in Zambia.
by: Enala T Mwase, et al.
Published: (2014)

Alternative approaches to lymphoedema care in lymphatic filariasis.
by: Suma Krishnasastry, et al.
Published: (2021)

Progress towards global elimination of lymphatic filariasis
by: Joseph Kamgno, et al.
Published: (2020)

Molecular xenomonitoring of diurnally subperiodic Wuchereria bancrofti infection in Aedes (Downsiomyia) niveus (Ludlow, 1903) after nine rounds of Mass Drug Administration in Nancowry Islands, Andaman and Nicobar Islands, India.
by: Addepalli Premkumar, et al.
Published: (2020)

The impact of the National Programme to Eliminate Lymphatic Filariasis on filariasis morbidity in Sri Lanka: Comparison of current status with retrospective data following the elimination of lymphatic filariasis as a public health problem.
by: Indeewarie E Gunaratna, et al.
Published: (2024)

Population migration: implications for lymphatic filariasis elimination programmes.
by: K D Ramaiah
Published: (2013)

Prevalence of malaria and lymphatic filariasis in bateyes of the Dominican Republic
by: Hunter M. Keys, et al.
Published: (2019)

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
by: Yakuba M Bah, et al.
Published: (2020)

A game-theoretic model of lymphatic filariasis prevention.
by: Jan Rychtář, et al.
Published: (2022)

Mid-term assessment of the lymphatic filariasis elimination program
by: Saurabh Rambiharilal Shrivastava, et al.
Published: (2016)

Using intervention mapping to design and implement quality improvement strategies towards elimination of lymphatic filariasis in Northern Ghana.
by: Alfred Kwesi Manyeh, et al.
Published: (2019)